Latest Company Announcements News

Alterity Therapeutics has secured encouraging regulatory feedback from the FDA on its ATH434 Phase 3 program for Multiple System Atrophy, marking a critical step towards pivotal trial initiation.

Boab Metals has received the crucial regulatory green light for its Sorby Hills project, clearing the way for full-scale mining operations and first concentrate production targeted in late 2027.

FIN Resources has successfully completed the first drill hole at its Cabin Lake Gold Project, intersecting a significant 38m zone of sulphide mineralisation that validates its geological model. Assay results are pending as drilling advances to the next target.

Western Mines Group has signed a Memorandum of Understanding with Magnium Australia to explore supplying magnesite from the Mulga Tank Project for low-carbon magnesium metal production. This collaboration could add a new revenue stream by monetising a previously overlooked magnesite cap.

Cavalier Resources has signed non-binding term sheets for a combined US$13 million gold prepayment and A$5 million gold loan to fund the Stage 1 development of its Crawford Gold Project, significantly improving project economics and financial flexibility amid softening gold prices.

Klevo Rewards’ subsidiary Fly Wallet has engaged top-tier law firm Hamilton Locke to establish the legal framework for its upcoming KLV stablecoin, aiming to ensure regulatory compliance in Australia’s evolving digital asset landscape.

Clarity Pharmaceuticals has signed a significant manufacturing supply agreement with Theragenics to produce copper-64, a key isotope for its upcoming prostate cancer diagnostic, Cu-SAR-bisPSMA. This deal strengthens Clarity’s US supply network ahead of anticipated FDA approval and commercial launch.

Carnaby Resources has reported exceptional high-grade copper-gold drill results from the Trek 1 extension at its Greater Duchess Project, revealing significant down-plunge continuity that promises to boost the project’s mineral inventory.

Athena Resources has entered a strategic joint venture with Terra Mining and Fenix Resources to accelerate development of premium magnetite concentrate at the Narryer Prospect, aiming for production by early 2028.

Cleo Diagnostics has expanded its ovarian cancer biomarker panel from five to eight markers, enhancing test reliability and gearing up for FDA submission. A manufacturing deal is imminent, setting the stage for commercial rollout.

Unico Silver Limited reports compelling high-grade gold-silver assay results from its Joaquin Project, confirming new shallow oxide mineralisation at Breccia Puntudo and extending mineralisation at La Negra SE beyond current resource boundaries.

Patrys has initiated manufacturing and regulatory steps for RLS-2201, its injectable Quetiapine formulation targeting delirium, aiming for Phase 0 trials in the second half of 2026.